WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ARWR past revenue growth

How has ARWR's revenue growth performed historically?
Company
-34.71%
Industry
151.46%
Market
17.61%
ARWR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ARWR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ARWR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ARWR earnings and revenue history

Current Revenue
$181.7M
Current Earnings
-$296.8M
Current Profit Margin
-163.3%

ARWR Return on Equity

Current Company
-95.5%
Current Industry
-63.5%
Current Market
188%
ARWR's Return on Equity (-95.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ARWR announces earnings.

ARWR Return on Assets

Current Company
-38.6%
Current Industry
2.9%
ARWR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ARWR Return on Capital Employed

Current Company
-49.15%
Current Industry
19.5%
ARWR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARWR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ARWR$181.74M-$262.45M-$296.81M+30.90%N/A
IDYA$23.39M-$108.95M-$112.96M+58.18%N/A
ACAD$726.44M-$45.48M-$61.29M+26.55%N/A
IMCR$249.43M-$50.00M-$55.29M+53.19%N/A
ACLX$110.32M-$44.26M-$70.69MN/AN/A
View Top Biotech Stocks

ARWR earnings dates

Next earnings date
Apr 30, 2024

Arrowhead Pharmaceuticals Earnings & Revenue FAQ

What were ARWR's earnings last quarter?

On Invalid Date, Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q4 2023 earnings per share (EPS) of -$1.24, up 217.95% year over year. Total Arrowhead Pharmaceuticals earnings for the quarter were -$132.86 million. In the same quarter last year, Arrowhead Pharmaceuticals's earnings per share (EPS) was -$0.39.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.

What was ARWR's earnings growth in the past year?

As of Q2 2024, Arrowhead Pharmaceuticals's earnings has grown year over year. Arrowhead Pharmaceuticals's earnings in the past year totalled -$296.81 million.

What is ARWR's earnings date?

Arrowhead Pharmaceuticals's earnings date is Invalid Date. Add ARWR to your watchlist to be reminded of ARWR's next earnings announcement.

What was ARWR's revenue last quarter?

On Invalid Date, Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q4 2023 revenue of $3.55 million up 94.32% year over year. In the same quarter last year, Arrowhead Pharmaceuticals's revenue was $62.55 million.

What was ARWR's revenue growth in the past year?

As of Q2 2024, Arrowhead Pharmaceuticals's revenue has grown -34.71% year over year. This is 186.16 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Arrowhead Pharmaceuticals's revenue in the past year totalled $181.74 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.